Podcast
Questions and Answers
Which risk score outperformed the Framingham-AF and ARIC risk models and was comparable to the CHARGE-AF risk score?
Which risk score outperformed the Framingham-AF and ARIC risk models and was comparable to the CHARGE-AF risk score?
- ARIC risk score
- Framingham-AF risk score
- CHARGE-AF risk score
- HARMS2-AF risk score (correct)
What is the incidence of AF among UKB patients?
What is the incidence of AF among UKB patients?
- 8.2%
- 6.9%
- 4.3%
- 5.7% (correct)
Which of the following is not a predictor of AF according to the HARMS2-AF risk score?
Which of the following is not a predictor of AF according to the HARMS2-AF risk score?
- Raised BMI
- Diabetes (correct)
- Age
- Hypertension
What is considered an intermediate risk score according to the HARMS2-AF risk score?
What is considered an intermediate risk score according to the HARMS2-AF risk score?
What is the main benefit of the HARMS2-AF risk score?
What is the main benefit of the HARMS2-AF risk score?
Which study investigated the effect of home telemonitoring systems (hTMS) on clinical outcomes in patients with HF?
Which study investigated the effect of home telemonitoring systems (hTMS) on clinical outcomes in patients with HF?
What was the reduction in all-cause mortality in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in all-cause mortality in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in first HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in first HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in total HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in total HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the main driver of mortality reduction in patients using hTMS according to the meta-analysis?
What was the main driver of mortality reduction in patients using hTMS according to the meta-analysis?
Which population was used to develop the HARMS2-AF risk score?
Which population was used to develop the HARMS2-AF risk score?
What is the incidence of AF among UK Biobank participants?
What is the incidence of AF among UK Biobank participants?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
What was the median time to AF among UK Biobank participants?
What was the median time to AF among UK Biobank participants?
What was the purpose of the Dutch study mentioned in the text?
What was the purpose of the Dutch study mentioned in the text?
What did the local study in NZ find about ethnic inequities in HF hospitalizations?
What did the local study in NZ find about ethnic inequities in HF hospitalizations?
What was the topic of the article about upgrading from right ventricular pacing to CRT?
What was the topic of the article about upgrading from right ventricular pacing to CRT?
What was the topic of the article about semaglutide?
What was the topic of the article about semaglutide?
What was the topic of the article comparing optical coherence tomography and angiography guidance?
What was the topic of the article comparing optical coherence tomography and angiography guidance?
What was the topic of the article about ferric carboxymaltose?
What was the topic of the article about ferric carboxymaltose?
According to the meta-analysis, what was the reduction in all-cause mortality in patients using home telemonitoring systems (hTMS) compared to standard of care?
According to the meta-analysis, what was the reduction in all-cause mortality in patients using home telemonitoring systems (hTMS) compared to standard of care?
What is the range for an intermediate risk score according to the HARMS2-AF risk score?
What is the range for an intermediate risk score according to the HARMS2-AF risk score?
What was the incidence of atrial fibrillation (AF) among UK Biobank (UKB) participants?
What was the incidence of atrial fibrillation (AF) among UK Biobank (UKB) participants?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
Which risk score outperformed the Framingham-AF and ARIC risk models and was comparable to the CHARGE-AF risk score?
Which risk score outperformed the Framingham-AF and ARIC risk models and was comparable to the CHARGE-AF risk score?
What was the main driver of mortality reduction in patients using home telemonitoring systems (hTMS) according to the meta-analysis?
What was the main driver of mortality reduction in patients using home telemonitoring systems (hTMS) according to the meta-analysis?
Which study investigated the effect of home telemonitoring systems (hTMS) on clinical outcomes in patients with heart failure (HF)?
Which study investigated the effect of home telemonitoring systems (hTMS) on clinical outcomes in patients with heart failure (HF)?
What was the reduction in first heart failure (HF) hospitalizations in patients using home telemonitoring systems (hTMS) compared to standard of care according to the meta-analysis?
What was the reduction in first heart failure (HF) hospitalizations in patients using home telemonitoring systems (hTMS) compared to standard of care according to the meta-analysis?
What was the topic of the Dutch study mentioned in the text?
What was the topic of the Dutch study mentioned in the text?
What was the topic of the article comparing optical coherence tomography and angiography guidance?
What was the topic of the article comparing optical coherence tomography and angiography guidance?
Which lifestyle factors were found to be predictive variables for AF in the HARMS2-AF risk score?
Which lifestyle factors were found to be predictive variables for AF in the HARMS2-AF risk score?
What was the median time to AF among UK Biobank participants?
What was the median time to AF among UK Biobank participants?
What was the incidence of AF among UK Biobank participants?
What was the incidence of AF among UK Biobank participants?
What is considered an intermediate risk score according to the HARMS2-AF risk score?
What is considered an intermediate risk score according to the HARMS2-AF risk score?
What was the topic of the article about upgrading from right ventricular pacing to CRT?
What was the topic of the article about upgrading from right ventricular pacing to CRT?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
Which of the following variables were found to be predictive for AF in the HARMS2-AF risk score?
What was the reduction in total HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in total HF hospitalizations in patients using hTMS compared to standard of care according to the meta-analysis?
What was the topic of the article about ferric carboxymaltose?
What was the topic of the article about ferric carboxymaltose?
What was the reduction in all-cause mortality in patients using hTMS compared to standard of care according to the meta-analysis?
What was the reduction in all-cause mortality in patients using hTMS compared to standard of care according to the meta-analysis?
What was the purpose of the Dutch study mentioned in the text?
What was the purpose of the Dutch study mentioned in the text?
What was the primary outcome measure in the study?
What was the primary outcome measure in the study?
What was the difference in the percentage of predicted FEV1 between the treatment group and the placebo group at 4 weeks?
What was the difference in the percentage of predicted FEV1 between the treatment group and the placebo group at 4 weeks?
What was the rate of pulmonary exacerbations in the treatment group compared to the placebo group?
What was the rate of pulmonary exacerbations in the treatment group compared to the placebo group?
What was the difference in the respiratory domain score on the Cystic Fibrosis Questionnaire between the treatment group and the placebo group?
What was the difference in the respiratory domain score on the Cystic Fibrosis Questionnaire between the treatment group and the placebo group?
What was the difference in the sweat chloride concentration between the treatment group and the placebo group?
What was the difference in the sweat chloride concentration between the treatment group and the placebo group?
How long was the study duration?
How long was the study duration?
How many patients underwent randomization and received at least one dose of active treatment or placebo?
How many patients underwent randomization and received at least one dose of active treatment or placebo?
Who were the contributing authors of the article?
Who were the contributing authors of the article?
When was the article published?
When was the article published?
What is the DOI of the article?
What is the DOI of the article?
What is the primary end point of the phase 3 trial mentioned in the text?
What is the primary end point of the phase 3 trial mentioned in the text?
What is the most common mutation in patients with cystic fibrosis?
What is the most common mutation in patients with cystic fibrosis?
Which combination of drugs was used in the phase 2 trial mentioned in the text?
Which combination of drugs was used in the phase 2 trial mentioned in the text?
What is the age range of the patients included in the phase 3 trial?
What is the age range of the patients included in the phase 3 trial?
What was the duration of the phase 3 trial?
What was the duration of the phase 3 trial?
What was the design of the phase 3 trial?
What was the design of the phase 3 trial?
What was the genotype of the patients included in the phase 3 trial?
What was the genotype of the patients included in the phase 3 trial?
What was the aim of the phase 2 trial mentioned in the text?
What was the aim of the phase 2 trial mentioned in the text?
What is the name of the CFTR corrector used in the phase 2 trial?
What is the name of the CFTR corrector used in the phase 2 trial?
What was the primary outcome measure in the phase 2 trial?
What was the primary outcome measure in the phase 2 trial?
